Heartflow, Inc. reported significant financial growth in its latest quarterly filing, with revenues reaching $64.1 million for the three months ended June 30, 2026, a 48% increase from $43.4 million in the same period last year. For the first half of 2026, the company generated $116.7 million in revenue, up 45% from $80.6 million in the first half of 2025. This growth is attributed to a 74% increase in revenue case volume, driven by the continued adoption of the Heartflow Plaque Analysis, which benefited from expanded reimbursement coverage effective January 1, 2026.
Despite the revenue increase, Heartflow reported a net loss of $15.7 million for the second quarter of 2026, compared to a loss of $9.2 million in the same quarter of 2025. The loss for the first half of 2026 was $43.1 million, slightly higher than the $41.5 million loss recorded in the first half of 2025. The increase in losses is primarily due to rising operating expenses, which surged 53% to $71.1 million in the second quarter, driven by higher research and development costs and increased selling, general, and administrative expenses.
Operationally, Heartflow has expanded its customer base significantly, with over 750,000 patients assessed using its Heartflow Platform, including 219,000 in 2025 alone. The company has also launched new products, including the Heartflow PCI Navigator in April 2026, which aims to enhance procedural efficiency in revascularization strategies. The company anticipates launching its fifth product, Plaque Tracker, in 2027, which will enable longitudinal plaque analysis.
As of June 30, 2026, Heartflow had $246.8 million in cash, cash equivalents, and investments, down from $359.5 million at the end of 2025. The decrease is attributed to ongoing operating losses and investments in growth. The company expects to continue incurring losses as it scales operations and invests in research and development. However, management believes that existing cash and expected revenue will be sufficient to fund operations for at least the next 12 months.
Looking ahead, Heartflow aims to increase adoption of its Heartflow Platform among healthcare providers and expand its international presence. The company is focused on automating its production processes and enhancing the efficiency of its commercial model, which combines sales and account management teams to drive growth. Despite the challenges of competition and market conditions, Heartflow remains optimistic about its growth trajectory and the potential for its innovative solutions in the diagnosis and management of coronary artery disease.
About Heartflow, Inc.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.
View the complete official filing on the SEC website.
Read on SEC.gov